Top 10 Trends in Medicine, September 2014

Ryan Syrek


September 23, 2014

#7 Clinical Trend: Belsomra

The US Food and Drug Administration (FDA) recently approved Belsomra for the treatment of chronic insomnia. The drug is an orexin receptor antagonist and is the first approved drug of this type.

For more in-depth clinical information, see Suvorexant.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.